| |
| |
|
| Insider
Information: |
Heath-Chiozzi Margo |
| Relationship: |
|
| City: |
Hampton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
13,383 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$472,152 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,383 |
|
|
| Total
Value |
$472,152 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
1
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
2.0
|
| Percentage
Gain/Loss : |
 900.3%
|
9.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celldex Therapeutics Inc |
CLDX |
|
2024-06-03 |
13,383 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDX |
Celldex Therapeutics Inc |
SVP of Regulatory Affairs |
• – – |
2020-06-09 |
4 |
B |
$3.01 |
$3,005 |
D/D |
1,000 |
1,000 |
2.66 |
% |
|
| CLDX |
Celldex Therapeutics Inc |
SVP of Regulatory Affairs |
• – – |
2021-08-11 |
4 |
OE |
$9.02 |
$90,165 |
D/D |
10,000 |
11,247 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP of Regulatory Affairs |
• – – |
2021-11-01 |
4 |
OE |
$2.78 |
$1,668 |
D/D |
600 |
11,847 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP of Regulatory Affairs |
• – – |
2021-11-01 |
4 |
AS |
$41.71 |
$25,026 |
D/D |
(600) |
11,247 |
0 |
% |
|
| CLDX |
Celldex Therapeutics Inc |
SVP of Regulatory Affairs |
• – – |
2021-12-08 |
4 |
AS |
$40.00 |
$24,000 |
D/D |
(600) |
11,247 |
0 |
% |
|
| CLDX |
Celldex Therapeutics Inc |
SVP of Regulatory Affairs |
• – – |
2021-12-08 |
4 |
OE |
$2.78 |
$1,668 |
D/D |
600 |
11,847 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP OF REGULATORY AFFAIRS |
• – – |
2024-05-30 |
4 |
OE |
$2.78 |
$126,301 |
D/D |
33,719 |
45,813 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP OF REGULATORY AFFAIRS |
• – – |
2024-05-30 |
4 |
S |
$34.07 |
$1,319,156 |
D/D |
(38,719) |
7,094 |
0 |
% |
|
| CLDX |
Celldex Therapeutics Inc |
SVP OF REGULATORY AFFAIRS |
• – – |
2024-06-03 |
4 |
OE |
$9.02 |
$662,575 |
D/D |
64,658 |
71,752 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP OF REGULATORY AFFAIRS |
• – – |
2024-06-03 |
4 |
S |
$33.65 |
$1,964,088 |
D/D |
(58,369) |
13,383 |
0 |
% |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
